
Terranueva Corp. Stock Analysis TEQ.CN
Terranueva Corp. Engages in the research and development, innovation, and operation on cannabis based therapeutic treatment. The company is headquartered in L'Assomption, Quebec. The company went IPO on 2018-12-17. The Company, through its subsidiary, Terranueva Pharma Corporation, holds the necessary licenses from Health Canada. The company is focused on providing the Canadian and international markets with first-rate medicinal and recreational cannabis. The firm seeks to develop cannabis that meets the primary motivations of consumers: chronic pain, migraines, sleep disorders and anxiety. Its products may be distributed in clinic, pharmacy, dispensaries, its Website and for direct sale. The firm's Certification, Research and Development Unit (CRDU) is located in L'Assomption, Quebec, Canada. Its production approach is developed according to modular production principles. Its crops are cultivated in a computer-assisted, automated and controlled environment at all times.
Read More Terranueva Corp (TEQ.CN) Chart
Key Statistics of Terranueva Corp (TEQ.CN)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
CAD0.03Volume
12.00KP/E Ratio (TTM)
-52 Week Range
Market Cap
950.00KAvg. Volume
34.34KDividend Yield
-Financial Metrics & Statements of Terranueva Corp (TEQ.CN)
FAQ's for Terranueva Corp (TEQ.CN)
- According to Musaffa’s Shariah screening methodology, Terranueva Corp (TEQ.CN) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.